Gongdong Medical released its 2026 interim report on August 25, 2026. The company's total operating revenue was 588 million yuan, net profit attributable to the parent was 54.6923 million yuan, and net cash inflow from operating activities was 130 million yuan. The company's latest asset-liability ratio was 20.65%, up 0.01 percentage points from the previous quarter and up 1.39 percentage points from the same period last year. The latest gross margin was 30.51%, down 1.95 percentage points from the previous quarter and down 0.80 percentage points from the same period last year. The latest return on equity was 3.22%, and diluted earnings per share was 0.25 yuan. The company's latest total asset turnover was 0.27 times, inventory turnover was 3.05 times, the number of shareholders was 10,700, and the top ten shareholders held 159 million shares, accounting for 71.89% of the total share capital.
Zhejiang Gongdong Medical Technology Co LtdInterim report shows net profit of 54.69 million yuan, but gross margin declined; mixed financial results.
